Caraglia M - Search Results

1

Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.

Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Pinzòn-Daza ML, Giordano A, Desiderio V, Ghigo D, De Rosa G, Caraglia M, Riganti C. Kopecka J, et al. Among authors: caraglia m. Oncotarget. 2016 Apr 12;7(15):20753-72. doi: 10.18632/oncotarget.8012. Oncotarget. 2016. PMID: 26980746 Free PMC article.

2

Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells.

Caraglia M, Marra M, Mancinelli F, D'Ambrosio G, Massa R, Giordano A, Budillon A, Abbruzzese A, Bismuto E. Caraglia M, et al. J Cell Physiol. 2005 Aug;204(2):539-48. doi: 10.1002/jcp.20327. J Cell Physiol. 2005. PMID: 15754340

3

Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.

Caraglia M, Marra M, Budillon A, Meo G, Ricciardiello F, Bismuto E, Brachelente G, Francini G, Giordano A, Correale P, Abbruzzese A. Caraglia M, et al. Cancer Biol Ther. 2005 Oct;4(10):1159-67. doi: 10.4161/cbt.4.10.2206. Epub 2005 Oct 23. Cancer Biol Ther. 2005. PMID: 16294035 Free article.

4

R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.

Caraglia M, Marra M, Leonetti C, Meo G, D'Alessandro AM, Baldi A, Santini D, Tonini G, Bertieri R, Zupi G, Budillon A, Abbruzzese A. Caraglia M, et al. J Cell Physiol. 2007 May;211(2):533-43. doi: 10.1002/jcp.20960. J Cell Physiol. 2007. PMID: 17192846

5

The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).

Facchini G, Caraglia M, Santini D, Nasti G, Ottaiano A, Striano S, Maiolino P, Ruberto M, Fiore F, Tonini G, Budillon A, Iaffaioli RV, Zeppetella GL. Facchini G, et al. Among authors: caraglia m. J Exp Clin Cancer Res. 2007 Sep;26(3):307-12. J Exp Clin Cancer Res. 2007. PMID: 17987788 Clinical Trial.

6

Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.

Marra M, Santini D, Meo G, Vincenzi B, Zappavigna S, Baldi A, Rosolowski M, Tonini G, Loeffler M, Lupu R, Addeo SR, Abbruzzese A, Budillon A, Caraglia M. Marra M, et al. Among authors: caraglia m. Int J Cancer. 2009 Nov 1;125(9):2004-13. doi: 10.1002/ijc.24648. Int J Cancer. 2009. PMID: 19530242

7

Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.

Salzano G, Marra M, Porru M, Zappavigna S, Abbruzzese A, La Rotonda MI, Leonetti C, Caraglia M, De Rosa G. Salzano G, et al. Among authors: caraglia m. Int J Pharm. 2011 Jan 17;403(1-2):292-7. doi: 10.1016/j.ijpharm.2010.10.046. Epub 2010 Nov 3. Int J Pharm. 2011. PMID: 21055454

8

Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.

Marra M, Salzano G, Leonetti C, Tassone P, Scarsella M, Zappavigna S, Calimeri T, Franco R, Liguori G, Cigliana G, Ascani R, La Rotonda MI, Abbruzzese A, Tagliaferri P, Caraglia M, De Rosa G. Marra M, et al. Among authors: caraglia m. Nanomedicine. 2011 Dec;7(6):955-64. doi: 10.1016/j.nano.2011.03.004. Epub 2011 Mar 29. Nanomedicine. 2011. PMID: 21453789

9

New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.

Marra M, Salzano G, Leonetti C, Porru M, Franco R, Zappavigna S, Liguori G, Botti G, Chieffi P, Lamberti M, Vitale G, Abbruzzese A, La Rotonda MI, De Rosa G, Caraglia M. Marra M, et al. Among authors: caraglia m. Biotechnol Adv. 2012 Jan-Feb;30(1):302-9. doi: 10.1016/j.biotechadv.2011.06.018. Epub 2011 Jun 30. Biotechnol Adv. 2012. PMID: 21741464

10

Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.

Ferro M, Giuberti G, Zappavigna S, Perdonà S, Facchini G, Sperlongano P, Porto S, Di Lorenzo G, Buonerba C, Abbruzzese A, Altieri V, Caraglia M. Ferro M, et al. Among authors: caraglia m. Oncol Rep. 2012 Feb;27(2):409-15. doi: 10.3892/or.2011.1526. Epub 2011 Oct 31. Oncol Rep. 2012. PMID: 22052369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters